Marine Turned Comedian Says TBI is No Laughing Matter
...s fall victim to TBI each year, a new drug called oxycyte
has given reason to hope. Rosner has launched a ...lf. Rosner's mission is to convince the FDA to put oxycyte
on the "fast track" for approval.
This is a ...ng cases, but accelerating the approval course for oxycyte
would enable the drug to be in war zones within mo...
Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
...ing, and submission to the FDA of an Investigational New Drug (IND) application for the use of Oxycyte(R) for the treatment of decompression sickness. oxycyte
is the company's perfluorocarbon (PFC) therapeutic oxygen carrier.
For more color on what this agreement means to the company, please read today'...
Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
...) Gel, its new Oxycyte(R)-based cosmetic product. oxycyte
is the company's perfluorocarbon (PFC) therapeutic... named Dermacyte, is an oxygen-rich formulation of oxycyte
which we believe will promote skin health and othe... or partner Dermacyte Gel, Wundecyte, Acnecyte, or oxycyte
for any indications or that such licensees will ge...
Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
"I know only too well about the devastating effects of blast-related TBI and other wounds suffered by our military personnel. I believe oxycyte
can help them have a better and faster recovery and I want to help make it available as fast as possible. I'm excited about being a part of this with ...
Oxycyte in Medical Technology
Oxycyte in Biological Technology
Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
COSTA MESA, Calif., April 14 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced it has reached a development and commercial supply agreement with Hospira Inc.'s One 2 One(R) Global Pharmaceutical Services business unit to manufacture clinical-grade Ox...
Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
COSTA MESA, Calif., March 26 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that the company has added clinical trial sites in Israel for the planned Phase II dose escalation study of Oxycyte(R) in traumatic brain injury (TBI). Oxycyte
is the comp...
Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
...ection with the clinical investigator meeting, a formal initiating step for the Swiss Phase II clinical trial of Oxycyte(R) in traumatic brain injury. oxycyte
is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
The meeting will be webcast live with the webcast available via the investor r...
Oxygen Biotherapeutics, Inc. Expands Board of Directors
...increased from $250 million to over $600 million. Our board and company will be stronger with his involvement."
"I'm excited about the promise of oxycyte
and what I can see as the potential for this company. I'm looking forward to working with Chris and the other board members to help bring that potenti...